Literature DB >> 29181571

Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk. Response to comments by Bredemeier.

Julien Paccou1,2, Bernard Cortet3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29181571     DOI： 10.1007/s00198-017-4320-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  2 in total

1.  Comments on Mignot et al.: bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.

Authors:  Markus Bredemeier
Journal:  Osteoporos Int       Date:  2017-11-27       Impact factor: 4.507

2.  Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.

Authors:  M A Mignot; N Taisne; I Legroux; B Cortet; J Paccou
Journal:  Osteoporos Int       Date:  2017-09-05       Impact factor: 4.507
  2 in total
  1 in total

1.  MiR-21 nanocapsules promote early bone repair of osteoporotic fractures by stimulating the osteogenic differentiation of bone marrow mesenchymal stem cells.

Authors:  Xiaolei Sun; Xueping Li; Hongzhao Qi; Xin Hou; Jin Zhao; Xubo Yuan; Xinlong Ma
Journal:  J Orthop Translat       Date:  2020-05-19       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.